FMR LLC 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | FMR LLC | 7,996,931 7.900% | -1,029,766 (-11.41%) | Filing |
| 2024-11-12 09:55 am Purchase | 2024-11-08 | 13G | Dyne Therapeutics, Inc. DYN | FMR LLC | 9,026,697 8.990% | 9,026,697 (New Position) | Filing |